Joseph Belanoff, CEO, Director at Corcept Therapeutics, holds 2.83M shares in Corcept Therapeutics (Ticker: CORT). Most recently, Joseph Belanoff Bought $800,000 shares of Corcept Therapeutics on Jul 08, 2022 for an estimated value of 1.66M.
What is the percentage of profitable transactions made by Joseph Belanoff?
The percentage of profitable transactions made by Joseph Belanoff is 25%.
What is the average return per transaction made by Joseph Belanoff?
The average return per transaction made by Joseph Belanoff is -49.90%.
What stocks does Joseph Belanoff hold?
Joseph Belanoff holds: CORT stocks.
What was Joseph Belanoff’s latest transaction?
Joseph Belanoff latest transaction was an Informative Buy of $1.66M.
What was Joseph Belanoff's most profitable transaction?
Joseph Belanoff’s most profitable transaction was an Informative Sell of CORT stock on December 14, 2018. The return on the trade was 20.00%.
What is Joseph Belanoff's role in Corcept Therapeutics?
Joseph Belanoff's role in Corcept Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.